Overview

L-Arginine in the Treatment of Peripheral Arterial Disease

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
To assess the effects of L-arginine upon functional status (treadmill exercise testing; quality of life) and limb blood (by mercury strain gauge plethysmography) in peripheral arterial disease.
Phase:
N/A
Details
Lead Sponsor:
Stanford University
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)